Amicus jumps 28 percent after FDA speeds approval process for drug

CNBC's Meg Tirrell reports on the Food and Drug Administration's reversal on a ruling to run an additional late clinical stage study for a rare disease drug.
00:39
Tue, Jul 11 201711:44 AM EDT